Search the GHTC website

Global health R&D delivers for Tennessee

US government investment in global health R&D has delivered

$64.1 million
to Tennessee research institutions
850+ new jobs
for Tennessee
Tennessee's top USG-funded global health R&D institutions

Tennessee's top USG-funded global health R&D institutions

Vanderbilt University
$33.8 million
St. Jude Children's Research Hospital
$15 million
The University of Tennessee Health Science Center
$9.8 million
Meharry Medical College
$5.5 million
Tennessee industry in global health R&D

Tennessee industry in global health R&D

Immuno Technologies
Location(s): Memphis
Location(s): Chattanooga

Tennessee's top areas of global health R&D by USG funding

Diarrheal diseases
Neglected tropical diseases
Global health R&D at work in Tennessee

Vanderbilt University researchers are working to stop mosquitoes from spreading disease. Their method uses Wolbachia, a bacterium found in more than 60 percent of the world’s insects. In mosquitoes, it hijacks their reproduction so that mostly only offspring carrying Wolbachia survive. Remarkably, it also prevents mosquitoes from carrying viruses like dengue and Zika. The scientists identified the two genes responsible for Wolbachia’s unique powers and found they can insert the genes directly into the insects’ genetic material, increasing the rate at which it spreads. These discoveries hold great promise for controlling the spread of insect-borne diseases.

  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: Dean Calma/IAEA